tm logo
BIOLUTE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 02 Jul 2018

Last Applicant/ Owned by

Ackerstrasse 6

8180 Bülach

CH

Serial Number

86104231 filed on 29th Oct 2013

Registration Number

N/A

Correspondent Address

Jennifer Fraser

JENNIFER FRASER

Suite 1100 West

1301 K Street N.W.

Washington DC 20005

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

BIOLUTE

Chemical coatings used in the manufacture of medical stents; Chemical and biochemical preparations for industrial and scientific purposes, namely, polylactide, polymers and silicone Chemical or pharmaceutical preparations for medical purposes, namely, polymerdrug preparations, namely, polymer-drug preparation, namely, polylactide-limus preparations, namely, drug preparations in the nature of drug Read More

Classification Information


Class [001]
Chemical Products


Chemical coatings used in the manufacture of medical stents; Chemical and biochemical preparations for industrial and scientific purposes, namely, polylactide, polymers and silicone

Class [005]
Pharmaceutical Products


Chemical or pharmaceutical preparations for medical purposes, namely, polymerdrug preparations, namely, polymer-drug preparation, namely, polylactide-limus preparations, namely, drug preparations in the nature of drug delivery agents in the form of a coating that facilitate the delivery of pharmaceutical preparations; chemical or pharmaceutical preparations, namely, delivery agents in the form of a coating for medical stents that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, a drug delivery system comprising polymer-based coatings for the release of a wide variety of therapeutic agents; chemical pharmaceutical preparations for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; drugs, namely, paclitaxel, and limus drug family, in particular sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for medical purposes for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; surgical implants comprising living tissues ; medicines for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation for human purposes

Class [010]
Medical Instrument Products


Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants and apparatus in the nature of stents; coatings for medical devices or chemical or pharmaceutical preparations used for stents, namely, coatings sold as an integral component of medical stents; surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; Catheters and parts therefor, catheters for percutaneous coronary intervention (PCI), catheters for percutaneous transluminal coronary angioplasty (PTCA catheters), and catheters for percutaneous transluminal angioplasty (PTA catheters), in particular catheters for balloon dilatation; medical guidewires; medical apparatus and instruments, namely, balloons and stents and parts therefor, balloon expandable stents, self expandable stents, drug eluting stents, absorbable stents, and absorbable implantable scaffolds comprising artificial materials, coronary and peripheral balloon catheters, drug eluting balloons, drug releasing balloons, drug coated balloons

Mark Details


Serial Number

No 86104231

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 067243-0015

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Jul 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
02th Jul 2018ABANDONMENT - NO USE STATEMENT FILED
29th Nov 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Nov 2017EXTENSION 5 GRANTED
27th Nov 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
21st Nov 2017EXTENSION 5 FILED
21st Nov 2017TEAS EXTENSION RECEIVED
08th Apr 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Apr 2017EXTENSION 4 FILED
05th Apr 2017EXTENSION 4 GRANTED